Answers are grounded in this paper and cite their sources.
Findings demonstrate trastuzumab-decorated nanoparticles induce plasma membrane changes in Her2 breast cancer cells, suggesting potential therapeutic strategies.
PLGA nanoparticles decorated with trastuzumab inducing HER receptor clustering on the surface of breast cancer cells causing rapid plasma membrane reorganization captured by live resonant scanning confocal microscopy and SEM.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: